Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Orchid Pharma Limited · Formerly Orchid Chemicals & Pharmaceuticals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993 on BSE, Jul 2007 on NSE
Last close ₹847.30up ₹10.85 (1.30%)BSE ₹846.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹836.45.
2 Nov: open ₹839.20, high ₹861.15, low ₹821.00
52-week range of traded prices to 2 Nov 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,074 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,09,48449.1% delivered
Orchid Pharma share news and announcements
856 announcements, routine notices left out, newest first. Page 11 of 18.
Jul 2016
29 Jul · Statement on Impact of Audit Qualifications
Jun 2016
May 2016
18 May · Board meeting
Apr 2016
Mar 2016
Feb 2016
Jan 2016
Dec 2015
15 Dec · Name and Symbol Change
Members of the Exchange are hereby informed that the name of the Company Orchid Chemicals & Pharmaceuticals Limited shall be changed to Orchid Pharma Limited and the trading symbol of the Company shall be changed from ORCHIDCHEM to ORCHIDPHAR w.e.f. December 21, 2015.
Nov 2015
Oct 2015
Sep 2015
16 Sep · News Verification
News about Orchid Chemicals & Pharmaceuticals Limited.The media had reports that "Orchid Pharmaceuticals in talks with banks to rejig debt".The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Orchid Chemicals & Pharmaceuticals Limited has vide its letter inter-alia stated, "The company is currently in talks with banks to explore the possibility of converting its rupee debt into dollar denominated debt. This plan is to try and reduce the interest burden on the company which will ultimately be beneficial to the company's bottom line. We will keep the stock exchanges informed as and when further developments take place."16 Sep · News Verification
Exchange has sought clarification from Orchid Chemicals & Pharmaceuticals Ltd., with respect to recent news item captioned "Orchid Pharmaceuticals in talks with banks to rejig debt". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Aug 2015
Jul 2015
27 Jul · Code of Conduct under SEBI(PIT) Reg., 2015
Jun 2015
May 2015
Apr 2015
Mar 2015
27 Mar · Board meeting
Feb 2015
2 Feb · Board meeting
To take on record the unaudited financial results of Orchid for the period from October 01, 2014 to December 31, 2014.
Dec 2014
Nov 2014